29 Nov 2018 Antares Pharma Announces The Commercial Availability Of XYOSTED™ (Testosterone Enanthate ) Injection – A New Treatment For Adult Men Diagnosed With Testosterone Deficiency Read More
27 Nov 2018 Antares Pharma Partner TEVA Announces Commercial Availability of Generic EpiPen Read More
26 Nov 2018 Antares Pharma to Present at the 30th Annual Piper Jaffray Healthcare Conference Read More
